Li R - Search Results

1

Predicting breast cancer prognosis using PR and PIK3CA biomarkers: a comparative analysis of diagnostic groups.

Feng Y, Song Q, Yan L, Li R, Yang M, Bu P, Lian J. Feng Y, et al. Among authors: li r. BMC Cancer. 2025 Jan 13;25(1):68. doi: 10.1186/s12885-025-13449-w. BMC Cancer. 2025. PMID: 39806274 Free PMC article.

2

Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer.

Li RQ, Yan L, Zhang L, Ma HX, Wang HW, Bu P, Xi YF, Lian J. Li RQ, et al. Sci Rep. 2024 May 29;14(1):12386. doi: 10.1038/s41598-024-62991-3. Sci Rep. 2024. PMID: 38811720 Free PMC article.

3

Identification of tumor antigens and immune subtypes in breast cancer for mRNA vaccine development.

Li RQ, Wang W, Yan L, Song LY, Guan X, Zhang W, Lian J. Li RQ, et al. Front Oncol. 2022 Sep 26;12:973712. doi: 10.3389/fonc.2022.973712. eCollection 2022. Front Oncol. 2022. PMID: 36226063 Free PMC article.

4

CD74 as a prognostic and M1 macrophage infiltration marker in a comprehensive pan-cancer analysis.

Li RQ, Yan L, Zhang L, Zhao Y, Lian J. Li RQ, et al. Sci Rep. 2024 Apr 7;14(1):8125. doi: 10.1038/s41598-024-58899-7. Sci Rep. 2024. PMID: 38582956 Free PMC article.

5

Development of a novel vasculogenic mimicry-associated gene signature for the prognostic assessment of osteosarcoma patients.

Yan L, Li R, Li D, Zhu Y, Lv Z, Wang B. Yan L, et al. Among authors: li d, li r. Clin Transl Oncol. 2023 Dec;25(12):3501-3518. doi: 10.1007/s12094-023-03218-1. Epub 2023 May 23. Clin Transl Oncol. 2023. PMID: 37219824

6

PSME2 offers value as a biomarker of M1 macrophage infiltration in pan-cancer and inhibits osteosarcoma malignant phenotypes.

Li R, Yan L, Jiu J, Liu H, Li D, Li X, Zhang J, Li S, Fan Z, Lv Z, Zhu Y, Wang B. Li R, et al. Among authors: li s, li d, li x. Int J Biol Sci. 2024 Feb 4;20(4):1452-1470. doi: 10.7150/ijbs.90226. eCollection 2024. Int J Biol Sci. 2024. PMID: 38385075 Free PMC article.

7

Various interventions for cancer-related fatigue in patients with breast cancer: a systematic review and network meta-analysis.

Li Y, Gao L, Chao Y, Lan T, Zhang J, Li R, Zhang Z, Li S, Lian J, Wang Z, Chen X. Li Y, et al. Among authors: li s, li r. Front Oncol. 2024 Feb 9;14:1341927. doi: 10.3389/fonc.2024.1341927. eCollection 2024. Front Oncol. 2024. PMID: 38406816 Free PMC article.

8

MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway.

Yan L, Zhou R, Feng Y, Li R, Zhang L, Pan Y, Qiao X, Li P, Wei X, Xu C, Li Y, Niu X, Sun X, Lv Z, Tian Z. Yan L, et al. Among authors: li y, li r, li p. Cell Death Discov. 2024 Apr 25;10(1):193. doi: 10.1038/s41420-024-01946-z. Cell Death Discov. 2024. PMID: 38664375 Free PMC article.

9

Early platelet elevation after complete remission as a prognostic marker of favourable outcomes in favourable- and intermediate-risk acute myeloid leukaemia: A retrospective study.

Wen X, Li R, Zhang X, Zhai J, Yang S, Wang Y, Tan Y, Xu Z, Yang L, Zhang R. Wen X, et al. Among authors: li r. J Clin Lab Anal. 2022 Feb;36(2):e24221. doi: 10.1002/jcla.24221. Epub 2022 Jan 3. J Clin Lab Anal. 2022. PMID: 34979042 Free PMC article.

10

[Impact of CSF3R Mutation on Treatment Response and Survival of Patients with Acute Myeloid Leukemia].

Li RQ, Wen XL, Zhang XL, Dong CX, Wang MF, Liu XX, Huang YJ, Tan YH, Chang JM, Zhang RJ. Li RQ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Jun;31(3):628-632. doi: 10.19746/j.cnki.issn.1009-2137.2023.03.002. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 37356918 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,584 results

Search Page

Filters